Oxytocin effects in schizophrenia: Reconciling mixed findings and moving forward

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

卷:80

Review

Bradley, Ellen R.¹  Woolley, Joshua D.¹ 

[1] Univ Calif San Francisco, Dept Psychiat, 401 Parnassus Ave, San Francisco, CA 94143 USA

关键词: Oxytocin;    Schizophrenia;    Negative symptoms;    Social cognition;   

DOI  :  10.1016/j.neubiorev.2017.05.007

来源: Elsevier

【 摘 要 】

Schizophrenia is a severe mental illness that causes major functional impairment. Current pharmacologic treatments are inadequate, particularly for addressing negative and cognitive symptoms of the disorder. Oxytocin, a neuropeptide known to moderate social behaviors, has been investigated as a potential therapeutic for schizophrenia in recent years. Results have been decidedly mixed, leading to controversy regarding oxytocin's utility. In this review, we outline several considerations for interpreting the extant literature and propose a focused agenda for future work that builds on the most compelling findings regarding oxytocin effects in schizophrenia to date. Specifically, we examine underlying causes of heterogeneity in randomized clinical trials (RCTs) conducted thus far and highlight the complexity of the human oxytocin system. We then review evidence of oxytocin's effects on specific deficits in schizophrenia, arguing for further study using objective, precise outcome measures in order to determine whether oxytocin has the potential to improve functional impairment in schizophrenia.

【 授权许可】

Free